Sphera Funds Management as of Dec. 31, 2019
Portfolio Holdings for Sphera Funds Management
Sphera Funds Management holds 85 positions in its portfolio as reported in the December 2019 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
SPDR S&P Biotech (XBI) | 21.9 | $266M | 2.8M | 95.11 | |
iShares NASDAQ Biotechnology Index (IBB) | 9.9 | $121M | 1.0M | 120.51 | |
Johnson & Johnson (JNJ) | 5.3 | $64M | 439k | 145.87 | |
Bristol Myers Squibb (BMY) | 4.8 | $59M | 915k | 64.19 | |
Sanofi-Aventis SA (SNY) | 4.7 | $57M | 1.1M | 50.20 | |
Merck & Co (MRK) | 4.2 | $51M | 555k | 90.95 | |
Novo Nordisk A/S (NVO) | 3.0 | $37M | 640k | 57.88 | |
Gilead Sciences (GILD) | 2.7 | $33M | 500k | 64.98 | |
Seattle Genetics | 2.4 | $29M | 250k | 114.26 | |
Amicus Therapeutics (FOLD) | 2.2 | $27M | 2.8M | 9.74 | |
BioMarin Pharmaceutical (BMRN) | 1.8 | $21M | 251k | 84.55 | |
Novartis (NVS) | 1.6 | $19M | 200k | 94.69 | |
Sarepta Therapeutics (SRPT) | 1.5 | $18M | 140k | 129.04 | |
Verint Systems (VRNT) | 1.3 | $16M | 291k | 55.36 | |
ACADIA Pharmaceuticals (ACAD) | 1.3 | $15M | 357k | 42.78 | |
Teva Pharmaceutical Industries (TEVA) | 1.2 | $15M | 1.5M | 9.80 | |
Alexion Pharmaceuticals | 1.0 | $13M | 116k | 108.15 | |
Mylan Nv | 0.9 | $11M | 560k | 20.10 | |
Ptc Therapeutics I (PTCT) | 0.8 | $10M | 215k | 48.03 | |
Ascendis Pharma A S (ASND) | 0.8 | $10M | 74k | 139.12 | |
Uniqure Nv (QURE) | 0.8 | $10M | 140k | 71.66 | |
Microsoft Corporation (MSFT) | 0.8 | $9.3M | 59k | 157.69 | |
Blueprint Medicines (BPMC) | 0.7 | $8.5M | 106k | 80.11 | |
Allot Communications (ALLT) | 0.7 | $8.3M | 971k | 8.50 | |
Rocket Pharmaceuticals (RCKT) | 0.7 | $8.2M | 362k | 22.76 | |
Exicure | 0.7 | $8.3M | 2.9M | 2.86 | |
Arvinas Ord (ARVN) | 0.7 | $8.2M | 199k | 41.09 | |
Gw Pharmaceuticals Plc ads | 0.7 | $8.1M | 77k | 104.56 | |
Proqr Thrapeutics N V shs euro (PRQR) | 0.7 | $8.0M | 805k | 9.91 | |
Audiocodes Ltd Com Stk (AUDC) | 0.7 | $7.9M | 306k | 25.69 | |
Fiserv (FI) | 0.6 | $7.8M | 67k | 115.62 | |
X4 Pharmaceuticals (XFOR) | 0.6 | $7.7M | 720k | 10.70 | |
Springworks Therapeutics (SWTX) | 0.6 | $7.7M | 200k | 38.49 | |
Portola Pharmaceuticals | 0.6 | $7.6M | 317k | 23.88 | |
Iveric Bio | 0.6 | $7.4M | 868k | 8.58 | |
Stoke Therapeutics (STOK) | 0.6 | $7.3M | 256k | 28.32 | |
Palo Alto Networks (PANW) | 0.6 | $7.2M | 31k | 231.24 | |
Zymeworks | 0.6 | $7.1M | 157k | 45.46 | |
Precision Biosciences Ord | 0.6 | $6.9M | 494k | 13.89 | |
Amazon (AMZN) | 0.6 | $6.8M | 3.7k | 1847.84 | |
Y Mabs Therapeutics (YMAB) | 0.6 | $6.7M | 213k | 31.25 | |
Karyopharm Therapeutics (KPTI) | 0.5 | $6.3M | 330k | 19.17 | |
Aldeyra Therapeutics (ALDX) | 0.5 | $6.2M | 1.1M | 5.81 | |
Galera Therapeutics (GRTX) | 0.5 | $6.2M | 471k | 13.16 | |
Minerva Neurosciences | 0.5 | $6.1M | 855k | 7.11 | |
ArQule | 0.5 | $5.9M | 297k | 19.96 | |
Proteostasis Therapeutics In | 0.5 | $5.8M | 2.5M | 2.28 | |
Bluebird Bio (BLUE) | 0.5 | $5.7M | 65k | 87.75 | |
Harpoon Therapeutics | 0.5 | $5.7M | 384k | 14.79 | |
Solaredge Technologies (SEDG) | 0.5 | $5.4M | 57k | 95.09 | |
Fiverr Intl Ltd ord (FVRR) | 0.5 | $5.5M | 234k | 23.50 | |
Caesar Stone Sdot Yam (CSTE) | 0.4 | $5.3M | 354k | 15.07 | |
Neos Therapeutics | 0.4 | $5.3M | 3.5M | 1.51 | |
Wix (WIX) | 0.4 | $5.1M | 41k | 122.37 | |
Ultragenyx Pharmaceutical (RARE) | 0.4 | $4.9M | 115k | 42.71 | |
Viking Therapeutics (VKTX) | 0.4 | $4.7M | 590k | 8.02 | |
Krystal Biotech (KRYS) | 0.4 | $4.8M | 86k | 55.38 | |
Principia Biopharma | 0.4 | $4.7M | 87k | 54.77 | |
Neoleukin Therapeutics | 0.4 | $4.7M | 380k | 12.32 | |
Burlington Stores (BURL) | 0.4 | $4.4M | 20k | 228.05 | |
Retrophin | 0.4 | $4.5M | 317k | 14.20 | |
Protagonist Therapeutics (PTGX) | 0.4 | $4.4M | 630k | 7.05 | |
Forescout Technologies | 0.4 | $4.5M | 137k | 32.80 | |
NOVA MEASURING Instruments L (NVMI) | 0.3 | $3.5M | 92k | 37.83 | |
Kornit Digital (KRNT) | 0.3 | $3.5M | 102k | 34.23 | |
Wabtec Corporation (WAB) | 0.3 | $3.1M | 40k | 77.80 | |
Cytokinetics (CYTK) | 0.2 | $2.9M | 269k | 10.61 | |
Kalvista Pharmaceuticals (KALV) | 0.2 | $2.6M | 148k | 17.81 | |
Argenx Se (ARGX) | 0.2 | $2.7M | 17k | 160.55 | |
Allena Pharmaceuticals | 0.2 | $2.5M | 918k | 2.73 | |
Immunovant Inc unit 12/18/2024 (IMVTU) | 0.2 | $2.5M | 100k | 24.87 | |
Abeona Therapeutics | 0.2 | $2.4M | 721k | 3.27 | |
Arya Sciences Acquisition Co unit 10/04/2023 | 0.2 | $2.3M | 200k | 11.50 | |
Adma Biologics (ADMA) | 0.2 | $2.2M | 540k | 4.00 | |
Axovant Gene The | 0.2 | $2.0M | 399k | 5.12 | |
Assembly Biosciences | 0.1 | $1.8M | 88k | 20.47 | |
Evolus (EOLS) | 0.1 | $1.8M | 150k | 12.17 | |
Concert Pharmaceuticals I equity | 0.1 | $1.3M | 140k | 9.23 | |
Inflarx Nv (IFRX) | 0.1 | $1.3M | 330k | 3.96 | |
Mellanox Technologies | 0.1 | $990k | 8.5k | 117.13 | |
Sunesis Pharmaceuticals Inc Ne | 0.1 | $728k | 2.1M | 0.34 | |
Bellicum Pharma | 0.0 | $516k | 400k | 1.29 | |
Zafgen | 0.0 | $386k | 348k | 1.11 | |
Immunovant (IMVT) | 0.0 | $317k | 20k | 15.85 | |
Cellectar Biosciences | 0.0 | $197k | 88k | 2.25 |